| Factor Information | |
|---|---|
| Data ID | 40 |
| Factor | Arterial cord blood PH value |
| Description | The median cord blood BNP was significantly higher (125 versus 31.90, p ¼ .032), whereas arterial cord blood pH values were significantly lower (7.29±0.12 versus 7.35±0.05, p ¼ .029) in the case subgroup without 6-month infant survival than in the case subgroup with 6-month surviva |
| Biomarker | YES |
| Classification | E10 (physiological factor - other) |
| Association | |
|---|---|
| Application | prognosis |
| Objective | To access the predict value of cord blood B-type natriuretic peptide and pH values with adverse outcomes |
| p Value | 0.029 |
| Conclusion | Neonates with congenital heart disease who have high cord blood B-type natriuretic peptide and low pH values may have adverse outcomes |
| Risk Factor | unknown |
| CHD Type | |
|---|---|
| ID | 148 |
| CHD Type | NA |
| CHD Subtype | NA |
| Reference | |
|---|---|
| PMID | 31256695 |
| Year | 2019 |
| Title | Maternal and cord blood homocysteine, vitamin B12, folate, and B-type natriuretic peptide levels at term for predicting congenital heart disease of the neonate: A case-control study |
| Sample | ||
|---|---|---|
| Population | adults | |
| Source | cord blood | |
| Region | Ankara, Turkey | |
| Method | a chemiluminescent microparticle immunoassay | |
| Race | Europe | |
| Disease History | N/A | |
| Treatment History | N/A | |
| Group | case group without 6-month fetal survival(Treatment) | case group with 6-month fetal survival(Control) |
| Number | 8 | 30 |
| Age | 29.79±4.49 (19–39)years(group with fetal CHD) | 29.79±4.49 (19–39)years(group with fetal CHD) |
| Gender (Male: Female) | 0:8 | 0:30 |
| Marker Level | 7.29±0.12 (7.0–7.35) | 7.35±0.05 (7.19–7.43)l |
